Response evaluation of SGLT2 inhibitor therapy in patients with type 2 diabetes mellitus using (18)F-FDG PET/MRI

INTRODUCTION: Inhibitors of sodium-glucose linked transporter-2 (SGLT2i) are enhancing glucose excretion in the proximal renal tubules, and thus are increasingly used to lower blood glucose levels in patients with type 2 diabetes mellitus (T2DM). The glucose analog 2-deoxy-2-((18)F) fluoro-D-glucose...

Descripción completa

Detalles Bibliográficos
Autores principales: Rasul, Sazan, Geist, Barbara Katharina, Brath, Helmut, Baltzer, Pascal, Sundar, Lalith Kumar Shiyam, Pichler, Verena, Mitterhauser, Markus, Kautzky-Willer, Alexandra, Hacker, Marcus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Emerging Technologies, Pharmacology and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206902/
https://www.ncbi.nlm.nih.gov/pubmed/32205328
http://dx.doi.org/10.1136/bmjdrc-2019-001135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206902/
https://www.ncbi.nlm.nih.gov/pubmed/32205328
http://dx.doi.org/10.1136/bmjdrc-2019-001135

Ejemplares similares